EP Patent

EP1560569A4 — Gastro-retentive levodopa delivery form

Assigned to Depomed Development Ltd · Expires 2006-03-22 · 20y expired

What this patent protects

Patent listed against pyridostigmine-bromide.

Drugs covered by this patent

pyridostigmine-bromide (PYRIDOSTIGMINE BROMIDE)

Patent Metadata

Patent number: EP1560569A4
Jurisdiction: EP
Classification: —
Expires: 2006-03-22
Drug substance claim: No
Drug product claim: No
Assignee: Depomed Development Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.